RE:RE:RE:Where are we now?Quattro74 wrote: Oh and regarding Roswell Park and what they could do for TLT is a wild card! ;-) I think that nsclc is at least a 20x larger market than nmibc, and that is if TLT owned 100% of that market, which we don't, yet.
Yep, Dr.McFarland is the only hope for the pps with this potential partnership with Roswell for NSCLC... having our TLD-1433 in the USA with a 2nd indication.. essentially with no cost to us.
non-small-cell-lung-cancer-therapeutics-market Non-Small-Cell-Lung-Cancer-Market-To-Reach-USD-10-53-Billion-By-2026 Then Dr.Mandel... of course never an update there...... How blasted long for basic Non GMP and GMP 'walk throughs'
Could have 2 more indications.. ready to go.. And where are the Brain Cancer Grants? even 1m bucks would cover 5-6 patients... at 100k a clip......
I use to post on grants.. usually you need to apply 1 year ahead of time?
Ill never fully accept the release of an incomplete report.... theres no reason to have nr'd it.
No way should we have 3 patients in 'question' of being 'binned' a CR or not... honestly i find it a bit funny that we're 1 patient below the 3/10 30% FDA threshold at the time this was released..
I bet all 3 had seeding in the upper tract and we see the 'undertreat' hit 58%... but how long will that report take.. and shouldn't we see an IMMEDIATE.. NR on that.
Hmm.